BioElectronics and YesDTC Holdings Receive Japanese Regulatory R... ( FREDERICK Md. Andrew Whelan CEO o...)

BioElectronics and YesDTC Holdings Receive Japanese Regulatory Review Date

Date:7/27/2010

FREDERICK, Md., July 27 /PRNewswire-FirstCall/ -- BioElectronics Corp. (Pink Sheets: BIEL), manufacturers of innovative pain relieving medical devices, today announced its distribution partner for Japan, YesDTC Holdings, Inc. (OTC Bulletin Board: YESD) has received notification from its legal staff of the pending review by Japanese government medical device regulators for the ActiPatch™ and Allay™ Menstrual Relief products. This review will take place on Wednesday, July 28th.

The initial analysis by YesDTC's attorneys has been very favorable toward the Company's ability to begin marketing in Japan as several similar devices are already on the market. This regulatory review is designed to verify that Japanese regulatory agencies will place ActiPatch and Allay in the same category as these currently marketed devices or if additional information and or testing will be required.

BioElectronics and YesDTC recently announced several important product line enhancements specifically tailored to suit the needs of the highly discerning and quality conscious Japanese marketplace. Additionally, upon release, BioElectronics will make the recently announced back pain belt available to the Japanese marketplace.

Andrew Whelan, CEO of BioElectronics, commented, "We view the Japanese market as being significant to our future success. There is a history of Japanese regulators closely mirroring the medical device classifications that had earlier occurred within the European Union, where we are a Class IIa device. This pending review, which will take place this week, should offer us a great deal of information about the timing in what we bel
'/>"/>

SOURCE BioElectronics Corp.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
2. BioElectronics Announces Major Clinical Trials
3. CardioGenics Holdings Inc. Receives New Ticker Symbol
4. Zimmer Holdings to Present at BMO Capital Markets Tenth Annual Focus on Healthcare Conference
5. Mastech Holdings, Inc. to Discuss Second Quarter 2010 Financial Results on July 28, 2010
6. RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc.
7. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Second Quarter 2010 Results
8. Bacterin International Holdings, Inc. Completes Merger and $7.5 Million Raise
9. Compass Diversified Holdings to Host Investor and Analyst Event on June 10, 2010
10. China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010
11. Zimmer Holdings to Present at Bairds 2010 Growth Stock Conference

Post Your Comments:

(Date:6/19/2013)... MUMBAI, India , June 19, ... Book Bureau has recently added DrugPatentWatch ... Databases. ( http://www.bharatbook.com/drugpatentwatch-tour.pdf ) ... DrugPatentWatch provides comprehensive information on pharmaceutical, ... value-added information supports the critical business ...

(Date:6/19/2013)... -- Nektar Therapeutics (Nasdaq: NKTR ) today ... study for NKTR-181, a first-in-class, opioid analgesic molecule ... slow rate of entry is designed to reduce the euphoria ... current opioid analgesics. 1 In the study data being ... in "drug liking" and "feeling high" scores and had highly ...

(Date:6/19/2013)... June 19, 2013 BD Biosciences, a segment of ... a leading global medical technology company, today announced the launch ... latest in its line of high-performance research flow cytometers. ... multicolor analysis with the most compact footprint in its class ... a height of 30" (76.2 cm). Recognizing that space is ...

[0] Drug Patent Watch [0] Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence [0] New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research

... , MINNEAPOLIS, Aug. 11 ProUroCare Medical, Inc. (OTC ... the required three centers in its FDA clinical study of the ... , ProUroCare began the current study with the ... having more than 40 patients enrolled overall. Since beginning, five ...

... Aug. 10 Bionovo, Inc. (Nasdaq: BNVI ) today announced second quarter ... , Company Highlights , , , ... in 27 patients with metastatic breast cancer showed ... evidence of clinical activity, in a heavily pretreated ...

Cached Medicine Technology:ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology 2 ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology 3 Bionovo Announces Second Quarter 2009 Highlights and Financial Results 2 Bionovo Announces Second Quarter 2009 Highlights and Financial Results 3 Bionovo Announces Second Quarter 2009 Highlights and Financial Results 4 Bionovo Announces Second Quarter 2009 Highlights and Financial Results 5 Bionovo Announces Second Quarter 2009 Highlights and Financial Results 6 Bionovo Announces Second Quarter 2009 Highlights and Financial Results 7 Bionovo Announces Second Quarter 2009 Highlights and Financial Results 8

ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology Bionovo Announces Second Quarter 2009 Highlights and Financial Results

(Date:6/19/2013)... of three important studies have been published in the ... the Congress of Neurological Surgeons . The ... , a part of Wolters Kluwer Health . ... artificial neural networks (ANNs) may improve the ability to ... study in the June Neurosurgery supports increased ...

(Date:6/19/2013)... 2013) In early April, senior leaders from medical, ... Connecticut, to discuss one question: how can first responders ... , The preliminary results of this discussion are now ... The Hartford Consensus ," a concept paper published in ... of Trauma and Acute Care Surgery , official ...

(Date:6/19/2013)... Could drugs that block the body,s system for repairing ... to health? As unlikely as it may seem, those ... and breast cancers driven by a mutation in BRCA, ... revealed she carries the mutation. The compounds, termed PARP ... the current edition of Chemical & Engineering News ...

(Date:6/19/2013)... 19, 2013 PREFERRED Therapy Providers, Inc. ... Arizona to offer a new Medicare Advantage Plan ... Paz, Yavapai and Mohave, Arizona counties. The agreement takes ... effective January 1, 2013 and Maricopa and Pima counties ... Inc., the parent company of WellCare of Arizona has ...

(Date:6/19/2013)... Kansas City will host its first Ciclovia event on Sept. ... section of Main Street in the midtown area will be restricted ... The Main Street Corridor Development and BikeWalkKC ... join the ranks of dozens of cities across the US and ... vibrancy and active lifestyles. , “Ciclovia is the perfect event for ...

Breaking Medicine News(10 mins):Health News:Neurosurgery publishes findings of 3 important studies in June issue 2 Health News:Neurosurgery publishes findings of 3 important studies in June issue 3 Health News:Hartford consensus aims to improve survival after mass shootings 2 Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2 Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2 Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3

[0] Neurosurgery publishes findings of 3 important studies in June issue [0] Hartford consensus aims to improve survival after mass shootings [0] Renewed hope in a once-abandoned cancer drug class [0] PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network [0] Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia

... healthcare,provider and supplier organizations with its GHXcellence Awards for,achievements ... Friday, April 18, 2008 during a recognition ceremony in,Chicago ... largest healthcare,forum in the U.S. focused on both the ... theme of this year,s awards was improved utilization of ...

... Once locked in decades of isolation, Albania is seeing new ... demands for better and healthier lives. , People ... Institute of Public Health and Hygiene. They want better, more ... keep pace with those expectations, but there are problems. , ...

... Fla., April 23 LifeSync Corporation, a,wholly ... it has entered,into a non-exclusive sublicense with ... with the digital, wireless communication of,patient vital ... Wireless the right to utilize,LifeSync,s technologies in ...

... The Beryl Companies, the nation,s,leading healthcare call ... of operations. In this role she will oversee ... recruitment and,training of managerial staff. Butterfield brings nearly ... vendor management., "Lindy is a highly regarded ...

... for cancer patients , , WEDNESDAY, April 23 (HealthDay News) ... developing a simple way to measure oxygen levels in ... treatment is best for individual patients. , The ... for patients with cancer instead of treating people the ...

... quarter of ... per share, including net realized investment losses ... cash flow was $1.0 billion, or approximately 1.8 times net ... income, -- Full year 2008 net income is now expected to be in the range of $5.42 -, ...

GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance Albania: Rising expectations drive growing health care needs LifeSync Corporation Agrees to Sublicense Patent Portfolio to Triage Wireless New VP of Operations Enhances The Beryl Companies' Leadership Team Scan Detects Oxygen Levels in Tumors WellPoint Reports First Quarter 2008 Results

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

Medicine Products:

Bile Duct Brushing for Cytology Bicarbonate (HCO3), Urine Bethesda Quantitative Factor VIII, Inhibitor, Quantitative Beta-hCG, Urine Qualitative